GlassScriptPhysician profile
Melody Maarouf
NPI 1982268504
$2,555.97
in general payments reported to CMS, 2019-2025
19 companies · $967 in 2025
The $967 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $301 · 2023: $698 · 2024: $468 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $744.69 | 2021-2025 | |
| Abbvie INC. | $387.82 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $261.40 | 2023-2025 | Zoryve |
| Ucb, INC. | $232.27 | 2024-2025 | Bimzelx |
| Leo Pharma INC. | $150.30 | 2022-2025 | Anzupgo, Adbry |
| Organon LLC | $143.46 | 2025 | Vtama |
| Janssen Biotech, INC. | $109.54 | 2022-2025 | Tremfya, Simponi, Stelara |
| E.R. Squibb & Sons, L.L.C. | $100.18 | 2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $73.25 | 2022-2024 | |
| Lilly USA, LLC | $61.97 | 2022-2025 | Ebglyss, Taltz |
| Kyowa Kirin, INC. | $60.51 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $49.21 | 2025 | Libtayo |
| Amgen INC. | $41.24 | 2024-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.28 | 2023 | Siliq |
| Revance Therapeutics, INC. | $30.42 | 2024 | Daxxify |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $23.85 | 2025 | Sofdra |
| Pfizer INC. | $21.29 | 2025 | |
| Galderma Laboratories, L.P. | $17.90 | 2025 | Nemluvio |
| Helsinn Therapeutics (U.S.), INC. | $15.39 | 2025 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Maarouf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.